The NIH Guide notices for some NIAID Funding Opportunities link to questions and answers (Q&As) specific to that opportunity, indexed here. This list is sorted by the date of the final scientific review meeting:
- Questions and Answers for RFA-AI-22-070 and RFA-AI-22-071, Autoimmunity Centers of Excellence, Clinical Research Program (U19 and UM1), scientific review in November 2023
- Questions and Answers for RFA-AI-22-076 and RFA-AI-22-077, Consortium for Food Allergy Research (CoFAR) Clinical Research Center (U01) and Leadership Center (UM1), scientific review in November 2023
- Questions and Answers for RFA-AI-23-019, RFA-AI-23-020, and RFA-AI-23-021, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP), scientific review in November 2023
- Questions and Answers for PAR-21-037, Global Infectious Disease Research Administration Development Award for Low- and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed), scientific reviews through December 2023
- Questions and Answers for RFA-AI-23-032, Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24, Clinical Trials Not Allowed), scientific review in February 2024
- Questions and Answers for PAR-20-082, NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44, Clinical Trial Required), scientific reviews through June 2024
- Questions and Answers for RFA-AI-23-055, Research Tools for Difficult to Culture Eukaryotic Pathogens, scientific review in July 2024
- Questions and Answers for PAR-20-072, NIAID Investigator-Initiated Program Project Applications (P01, Clinical Trial Not Allowed), scientific reviews through October 2025
- NIH Medical Scientist Partnership Program (MSPP)—Guidance and Q&A for Applicants, scientific reviews through November 2025
- Questions and Answers for PAR-23-275, NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01, Clinical Trial Optional), scientific reviews through November 2025
- Questions and Answers for RFA-AI-23-023, International Research in Infectious Diseases (R01 Clinical Trial Not Allowed), scientific reviews through November 2025
- Questions and Answers for PAR-23-198, NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed), scientific reviews through March 2026
- Questions and Answers for Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11, Clinical Trial Not Allowed), scientific reviews through July 2026
- Questions and Answers for Notice of Special Interest (NOSI)—Research on Early Allergy Determinants Using Biosamples from the SUNBEAM Birth Cohort, scientific reviews through November 2026
- Questions and Answers for NOT-AI-23-074, Notice of Special Interest (NOSI)—Administrative Supplement to Support Research Opportunities at NIAID Intramural Facilities, scientific review dates to be announced